NOMAD POWER SOLUTIONS, INC. Net Income (Loss) Attributable to Noncontrolling Interest
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$157.08 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-14
- NOMAD POWER SOLUTIONS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$157.08K.
- NOMAD POWER SOLUTIONS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$63.93K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month |
|---|---|---|
| 2026-06-30 | -$157.08K 10-Q · filed 2026-08-14 | -$221.01K 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$63.93K 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |